Regulation could save genome scanning, not kill it

Regulation could save genome scanning, not kill it


By Peter Aldhous ARE we witnessing the beginning of the end of “personal genomics”? After a bruising hearing in the US Congress last week, and with the Food and Drug Administration flexing its regulatory muscles, that is what some commentators predict. “There’s no question that the sheer scale and ferocity of this combined inquisition from the FDA and Congress will forever change the face of the personal genomics landscape,” wrote Daniel MacArthur in his Genetic Future blog, predicting “excessive, innovation-crushing regulation”. But this doesn’t have to be the end of the industry. If it embraces sensible regulation,
  • 首页
  • 游艇租赁
  • 电话
  • 关于我们